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ABSTRACT
Cartilage matrix homeostasis involves a dynamic balance between numerous signals that modulate chondrocyte functions. This study aimed
at elucidating the role of the extracellular glucose concentration in modulating anabolic and catabolic gene expression in normal and
osteoarthritic (OA) human chondrocytes and its ability to modify the gene expression responses induced by pro-anabolic stimuli, namely
Transforming Growth Factor-b (TGF). For this, we analyzed by real time RT-PCR the expression of articular cartilage matrix-speciﬁc and non-
speciﬁc genes, namely collagen types II and I, respectively. The expression of the matrix metalloproteinases (MMPs)-1 and -13, which plays a
major role in cartilage degradation in arthritic conditions, and of their tissue inhibitors (TIMP) was also measured. The results showed that
exposure to high glucose (30mM) increased the mRNA levels of both MMPs in OA chondrocytes, whereas in normal ones only MMP-1
increased. Collagen II mRNA was similarly increased in normal and OA chondrocytes, but the increase lasted longer in the later. Exposure to
high glucose for 24 h prevented TGF-induced downregulation of MMP-13 gene expression in normal and OA chondrocytes, while the
inhibitory effect of TGF on MMP-1 expression was only partially reduced. Other responses were not signiﬁcantly modiﬁed. In conclusion,
exposure of human chondrocytes to high glucose, as occurs in vivo in diabetes mellitus patients and in vitro for the production of engineered
cartilage, favors the chondrocyte catabolic program. This may promote articular cartilage degradation, facilitating OA development and/or
progression, as well as compromise the quality and consequent in vivo efﬁcacy of tissue engineered cartilage. J. Cell. Biochem. 112: 2813–
2824, 2011.  2011 Wiley-Liss, Inc.
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A rticular cartilage is a specialized connective tissue thatsupports and distributes loads and ensures a near-friction-
less motion in joints. These unique properties are due to the
structural organization of the main macromolecules that compose
the cartilage extracellular matrix, namely collagens and proteogly-
cans. Chondrocytes, the only cell type present in articular cartilage,
are embedded in the extracellular matrix and are responsible for
maintaining its homeostasis by ensuring the synthesis and turnover
of its components [Martel-Pelletier et al., 2008; Goldring andMarcu,
2009].
Cartilage matrix homeostasis involves a dynamic balance
between a variety of signals that modulate chondrocyte functions,
namely mechanical forces, cytokines and growth factors and cell–
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stimulating catabolic responses. Aging and mechanical stress of
joints are major risk factors for osteoarthritis (OA), but growing
evidence indicates that metabolic factors play an important role in
disease development and progression. For instance, a signiﬁcant
positive correlation was found between elevated blood glucose and
radiological evidence of OA [Hart et al., 1995]. Accordingly, OA is
increasingly envisaged as a ‘‘metabolic disorder’’ linked to obesity,
diabetes mellitus, dyslipidemia, hypertension, and insulin resistance
[Sturmer et al., 2001; Burner and Rosenthal, 2009; Siviero et al.,
2009; Pallu et al., 2010; Velasquez and Katz, 2010].
These conditions seem to favor the initiation and progression of
arthritic diseases, such as OA, by providing catabolic signals that
lead, among other responses, to increased production of proteolytic
enzymes. These degrade the matrix components causing progressive
cartilage destruction, the main feature of OA [Martel-Pelletier et al.,
2008; Goldring and Marcu, 2009].
Among the proteolytic enzymes, aggrecanases and colagenases
which belong to the Matrix MetalloProteases (MMPs) family are of
special importance [Arner, 2002; Nagase and Kashiwagi, 2003;
Burrage et al., 2006]. Collagenases cleave collagen triple helix ﬁbers,
leaving them susceptible to further degradation by other enzymes.
Human articular chondrocytes have been shown to express several
collagenases, among which collagenase-1 (MMP-1), -2 (MMP-8), and
-3 (MMP-13) are especially relevant since their expression is
increased by pro-inﬂammatory and catabolic stimuli [Arner, 2002;
Nagase and Kashiwagi, 2003; Burrage et al., 2006]. MMP-13, whose
expression has been shown to be augmented in OA cartilage [Bau
et al., 2002; Kevorkian et al., 2004], has a signiﬁcant role in cartilage
degradation and OA progression since it preferentially cleaves type II
collagen ﬁbers [Takaishi et al., 2008]. MMP-1, also participates in the
initial cleavage of collagen II, but with a lower activity than MMP-13
[Mitchell et al., 1996]. Type II collagen is a major macromolecule of
the extracellular matrix that confers structural support to cartilage. Its
enhanced degradation and consequent loss with associated cartilage
erosion is a key characteristic of OA pathophysiology. Allied to
increased matrix degradation, OA is characterized by a shift in the
chondrocyte anabolic activity, so that collagen II synthesis is replaced
by increased production of the non-cartilage matrix speciﬁc collagen
type I. This leads to the formation of a ﬁbrocartilaginous tissue which
is biomechanically less effective than articular cartilage [Miosge et al.,
2004; Tesche and Miosge, 2005].
The activity of MMPs can be negatively regulated at the post-
transcriptional level by members of the family of Tissue Inhibitors of
MetalloProteases (TIMPs) [Baker et al., 2002]. Among the TIMPs
identiﬁed in human chondrocytes, TIMP-2 has been reported to be
constitutively expressed and therefore suggested to have a role in
the maintenance of cartilage integrity in normal conditions, while
TIMP-1 and TIMP-3 seem to have a more important role in
pathological conditions [Zafarullah et al., 1996; Su et al., 1999].
High ratios of proteinase/inhibitors favor proteolysis and have been
found in the synovial ﬂuid of OA patients [Ishiguro et al., 1999].
Members of the MMP and TIMP families are inversely regulated at
the transcriptional level by catabolic stimuli, such as the pro-
inﬂammatory cytokines, Interleukin-1b (IL-1) and Tumor Necrosis
Factor-a (TNF), and by anabolic growth factors, namely Transform-
ing Growth Factor-b (TGF). The last is especially important since it
can act in articular chondrocytes in an autocrine and/or paracrine
way, inducing anabolic effects and inhibiting catabolic responses.
More speciﬁcally, TGF has been shown to stimulate proteoglycans,
collagen type II [Miyazaki et al., 2000; Martel-Pelletier et al., 2008]
and TIMPs expression [Wang et al., 2002], while reversing some of
the IL-1-induced catabolic effects [Seifarth et al., 2009].
Besides these well-characterized stimuli, chondrocytes respond to
and are inﬂuenced by other signals. Among these, the extracellular
glucose concentration, either increased or decreased, has been
shown to directly affect some chondrocyte functions [Kelley et al.,
1999; Richardson et al., 2003; McNulty et al., 2005]. In particular,
culture of rabbit chondrocytes in either low (<5mM) or high
(25mM) glucose concentrations decreased proteoglycan synthesis
induced by the anabolic growth factor, IGF-I [Kelley et al., 1999].
Exposure to increasing glucose concentrations, dose-dependently
decreased dehydroascorbate uptake by human chondrocytes
[McNulty et al., 2005], which may have functional implications
as dehydroascorbate is essential for collagen synthesis. Moreover,
our previous study showed that normal human chondrocytes adjust
to changes in the extracellular glucose concentration by regulating
glucose uptake, at least in part, through modulation of the cellular
content of the Glucose Transporter (GLUT)-1 [Rosa et al., 2009], a
member of the GLUT/SLC2A facilitative glucose transporter family.
Moreover, that study also showed that OA chondrocytes exposed to
a high, hyperglycemia-like extracellular glucose concentration
(30mM) were unable to reduce glucose transport and GLUT-1
content which led to increased glucose accumulation and prolonged
Reactive Oxygen Species (ROS) production [Rosa et al., 2009].
Increased oxidative stress has been pointed out as a major
pathogenic mechanism of OA [Maneiro et al., 2003; Grishko
et al., 2009], and at the cellular level, increased ROS production has
been shown to mediate many catabolic responses in chondrocytes
[Lo et al., 1998; Mendes et al., 2003a,b].
Thus, this study was undertaken to determine whether exposure
to a high extracellular glucose concentration can shift normal and
OA chondrocyte functions towards a pro-catabolic and/or anti-
anabolic gene expression proﬁle, either direct or indirectly by
modifying the responses induced by pro-anabolic stimuli, namely
TGF.
For this purpose, we examined by real time RT-PCR (qRT-PCR) the
expression of genes that are important for cartilage homeostasis and
OA pathogenesis and that in other cell types have been reported to be
modulated by exposure to high glucose [Death et al., 2003; Ho et al.,
2007; Andreea et al., 2008; Kim et al., 2008]. Those genes include the
MMPs-1 and -13 due to their major role in cartilage matrix
degradation, and collagen type II, TIMP-1 and TIMP-2 as important
anabolic and anti-catabolic genes, respectively. Collagen type I was
also assessed since it is frequently reported to be increased in OA,
representing the inability of OA chondrocytes to promote an
adequate cartilage matrix repair response [Miosge et al., 2004].
MATERIALS AND METHODS
CARTILAGE SAMPLES AND CHONDROCYTE CULTURE
Human knee cartilage was collected, within 12 h of death, from the
distal femoral condyles of multi-organ donors (18–40 years old,
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mean¼ 32, n¼ 7, normal cartilage) or with informed consent from
patients (50–71 years old, mean¼ 64, n¼ 11, OA cartilage)
undergoing total knee replacement surgery at the Orthopedic
Department of the University Hospital of Coimbra (HUC). The Ethics
Committee of HUC approved all procedures. Cartilage from all multi-
organ donors appeared grossly normal without macroscopic
changes other than some yellowish discoloration and, in a few
samples (aged >35 years old), small areas of slightly roughened
surface. Chondrocytes were isolated by enzymatic digestion as
described previously [Rosa et al., 2009]. Non-proliferating mono-
layer cultures were established from each cartilage sample, allowed
to recover in medium containing 5% fetal bovine serum for 24 h,
serum-starved overnight and maintained thereafter in serum-free
culture medium. The cells were subsequently cultured, for the
periods indicated in ﬁgures and ﬁgure legends, in Ham’s F-12
(Regular Glucose Medium, which contains 10mM glucose) or in the
same medium supplemented with 20mM D-glucose to yield a ﬁnal
glucose concentration of 30mM (High Glucose Medium). In selected
experiments, recombinant human TGF-b (Peprotech, Rocky Hill, NJ)
was used in the ﬁnal concentration of 10 ng/ml.
TOTAL RNA EXTRACTION AND cDNA PREPARATION
Total RNA was extracted with TRIzol (Invitrogen, Paisley, UK),
analyzed using Experion RNA StdSens Chip (Bio-Rad) and
quantiﬁed in a NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies, Inc., Wilmington, DE) at 260 nm. The cDNA was
reverse transcribed from 1mg of total RNA, using iScriptTM Select
cDNA Synthesis Kit (Bio-Rad), according to the manufacturer’s
instructions. The cDNA obtained was stored at 208C until further
analysis.
REAL-TIME REVERSE TRANSCRIPTASE-PCR (qRT-PCR)
Speciﬁc sets of primers were designed using Beacon Designer
software (PREMIER Biosoft International, Palo Alto, CA). Details of
the forward and reverse primers for the human genes evaluated are
presented in Table I. qRT-PCR was performed with iTaqTM DNA
polymerase using iQTM SYBR Green Supermix (BioRad). Thermal
cycling conditions included 3min at 958C to activate the iTaqTM
DNA polymerase, followed by 45 cycles, each consisting of a
denaturation step at 958C for 10 s, an annealing step at 548C for 30 s
and an elongation step at 728C for 30 s. Fluorescence measurements
were taken every cycle at the end of the annealing step and the
speciﬁcity of the ampliﬁcation products was checked by analysis of
the melting curve. The efﬁciency of the ampliﬁcation reaction for
each gene was calculated by running a standard curve of serially
diluted cDNA sample. In each assay, a control reaction without the
cDNA was also subjected to PCR ampliﬁcation.
Gene expression changes were analyzed using the built-in iQ5
Optical system software v2, which enables the analysis of the results
with the Pfafﬂmethod, a variation of theDDCTmethod corrected for
gene-speciﬁc efﬁciencies.
STATISTICAL ANALYSIS
In Figure 1, the nonparametric Mann–Whitney test was used to
compare the distributions of the basal expression of catabolic and
anabolic genes in normal and OA human chondrocytes. In all other
ﬁgures, the results are presented as the gene expression level relative
to the control situation (normal or OA chondrocytes maintained in
RGM). The statistical analysis was performed using the paired two-
tailed Student t-test to compare differences between the control and
the test situation or between the responses induced by treatment of
chondrocytes with TGF in RGM and in HGM, for the same incubation
period. To assess normality for the observed differences, a graphical
analysis based on normal quantile plots was used in all cases,
showing no strong departure from normality, thus supporting the
use of the Student t-test. Results were considered statistically
signiﬁcant for P< 0.05.
RESULTS
BASAL EXPRESSION OF ANABOLIC AND CATABOLIC GENES IN
NORMAL AND OA HUMAN CHONDROCYTES
The expression of MMPs-1 and -13, TIMPs-1 and -2 and collagen
types I and II was analyzed by qRT-PCR across cDNAs transcribed
from total RNA extracted from chondrocyte cultures obtained from
7 normal and 11 OA human knee cartilage samples. Previous studies
showed that HPRT-1 was the candidate housekeeping gene, among
seven tested, whose expression varied least between normal and OA
chondrocytes. Accordingly, HPRT-1 was used as reference gene for
comparisons of mRNA levels between normal and OA chondrocytes.
TABLE I. Oligonucleotide Primer Pairs Used for qRT-PCR
Gene name Primer sequences (50–30) RefSeq ID
Hypoxanthine phosphoribosyltransferase-1 (HPRT-1) F: TGA CAC TGG CAA AAC AAT NM_000194
R: GGC TTA TAT CCA ACA CTT CG
Matrix Metalloprotease-1 (MMP-1) F: GACTCTCCCATTCTACTG NM_002421
R: TTA TAG CAT CAA AGG TTA GC
Matrix Metalloprotease-13 (MMP-13) F: GTT TCC TAT CTA CAC CTA CAC NM_002427
R: CTC GGA GAC TGG TAA TGG
Tissue inhibitor of metalloproteinase-1 (TIMP-1) F: TGTTGCTGTGGCTGATAG NM_003254
R: CTGGTATAAGGTGGTCTGG
Tissue inhibitor of metalloproteinase-2 (TIMP-2) F: ACGATATACAGGCACATTATG NM_003255
R: GGTCAGGAGTCTTAACAGG
Collagen Type I (COL1A1) F: GGA GGA GAG TCA GGA AGG NM_000088
R: GCA ACA CAG TTA CAC AAG G
Collagen type II (COL2A1) F: GGC AGA GGT ATA ATG ATA AGG NM_001844
R: ATT ATG TCG TCG CAG AGG
F: Forward sequence; R: Reverse sequence.
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The box and whiskers plots presented in Figure 1A and B show
that, despite considerable interindividual variability and a few
outliers in both groups, basal MMP-1 and -13 mRNA levels were
signiﬁcantly higher in OA than in normal chondrocytes. On average,
MMP-1 and -13 mRNA levels were approximately ﬁve and eight
times higher in OA (118,011.7 39,681.4 and 11,926.9 3,215.4)
than in normal (24,243.6 10,100.4 and 1,469.7 694.9) chon-
drocytes, respectively. In all samples tested, either normal or OA,
MMP-1 was always detected at an earlier mean threshold cycle
than MMP-13, indicating a higher basal expression level of the
former.
On the other hand, the expression of TIMP-1 was signiﬁcantly
higher (approximately fourfold in average) in OA than in
normal chondrocytes (Fig. 1C, P¼ 0.04). TIMP-2 mRNA levels,
however, were only 1.7-fold higher in OA than in normal
chondrocytes and the difference did not reach statistical signiﬁ-
cance (Fig. 1D, P¼ 0.54).
Concerning themRNA expression of collagens I and II, a tendency
to increased levels of collagen II in normal and to elevated levels of
collagen I in OA chondrocytes was observed (Fig. 1E and F),
although those differences did not reach statistical signiﬁcance.
Moreover, the ratio of collagen II over collagen I mRNA levels (Col
Fig. 1. Basal expression of catabolic and anabolic genes in normal and OA human chondrocytes. Box and whiskers plots of the mRNA levels of MMPs-1 (A) and -13 (B), TIMPs-
1 (C) and -2 (D) and collagens I (E) and II (F) in normal (n¼ 7) and OA (n¼ 11) chondrocytes. The boxes represent the distribution of mRNA levels between the 25th and 75th
percentiles, while the bars (whiskers) represent extreme values outside that range. The line dividing each box represents the median of the distribution, that is, the central mRNA
value for which there is an equal number of samples with mRNA values above and below that one. P< 0.05 and P< 0.01.
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II/Col I) was on average 3.5-fold higher in normal than in OA
chondrocytes, but again the difference did not reach statistical
signiﬁcance (P¼ 0.07).
ROLE OF HIGH GLUCOSE IN MODULATING THE EXPRESSION OF THE
CATABOLIC GENES, MMP-1 AND -13
The results obtained show that in normal chondrocytes, MMP-1
mRNA levels (Fig. 2A) relative to chondrocytes cultured in regular
glucose medium (RGM, 10mM glucose) decreased upon exposure to
high glucose (HGM, 30mM glucose) for 48 and 72 h, while MMP-13
mRNA levels (Fig. 2C) remained unchanged regardless of the
duration of exposure to high glucose. In OA chondrocytes, both
MMP-1 (Fig. 2B) and -13 (Fig. 2D) mRNA levels were similarly
increased by culture in HGM for 24, 48, and 72 h. Nonetheless, the
differences observed for MMP-1 at 24 and 48 h did not reach
statistical signiﬁcance.
ROLE OF HIGH GLUCOSE ON TIMP-1 AND -2 EXPRESSION
The results shown in Figure 3A indicate that the expression of TIMP-
1 was decreased by culture of normal chondrocytes in HGM for 48
and 72 h, while no signiﬁcant changes were found in OA
chondrocytes (Fig. 3B). TIMP-2 mRNA levels were signiﬁcantly
upregulated in normal (Fig. 3C), but not in OA (Fig. 3D)
chondrocytes upon exposure to high glucose for 24 h. No signiﬁcant
Fig. 2. Role of high glucose in modulating the expression of MMP-1 and MMP-13 genes in normal and OA chondrocytes. Relative MMP-1 (A, B) and MMP-13 (C, D) mRNA
levels in normal (n¼ 5) and OA (n¼ 6) chondrocytes cultured in medium with an elevated (30mM) glucose concentration (HGM) for 24, 48, and 72 h or maintained in medium
with the regular glucose concentration (RGM) for the entire experiment (normal and OA controls). Each bar represents the mean SD. P< 0.05 and P< 0.001 relative to the
respective control.
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differences relative to cells maintained in RGM were found at the
other time points, either in normal (Fig. 3C) or OA chondrocytes
(Fig. 3D).
ROLE OF HIGH GLUCOSE ON COLLAGEN TYPE I AND II EXPRESSION
Figure 4A and B shows that culture of normal and OA chondrocytes,
respectively, in HGM for 24, 48, or 72 h did not signiﬁcantly affect
collagen type I expression relative to the respective control cells
maintained in RGM.
On the other hand, culture in HGM for 24 h similarly increased
collagen II mRNA levels in normal (1.3 0.07, Fig. 4C) and OA
(1.3 0.13, Fig. 4D) chondrocyte cultures. This increase, although
lower, was still signiﬁcant after incubation of OA chondrocytes in
HGM for 48 h. After 72 h, however, collagen II mRNA levels both in
normal and OA chondrocytes had returned to those found in the
respective control cells maintained in RGM.
ROLE OF HIGH GLUCOSE IN MODULATING MMP-1 AND -13 GENE
EXPRESSION PROFILES INDUCED BY TGF IN NORMAL AND OA
CHONDROCYTES
To determine whether exposure to high glucose can modify
chondrocyte responses to TGF, the gene expression proﬁles of
MMP-1 and -13 were evaluated in normal and OA chondrocytes
treated with TGF for various time periods in the presence or absence
of high glucose (HGM). The results were normalized using HPRT-1 as
the housekeeping gene since its expression was not signiﬁcantly
affected by treatment of normal and OA chondrocytes with TGF.
Treatment with TGF for 24h induced a marked decrease in MMP-1
mRNA levels in normal (0.31 0.015, Fig. 5A) and OA (0.38 0.05,
Fig. 3. Role of high glucose in modulating the expression of TIMP-1 and TIMP-2 genes in normal and OA chondrocytes. Relative TIMP-1 (A, B) and TIMP-2 (C, D) mRNA levels
in normal (n¼ 6) and OA (n¼ 6) chondrocytes cultured in medium with an elevated (30mM) glucose concentration (HGM) for 24, 48, and 72 h or maintained in medium with
the regular glucose concentration (RGM) for the entire experiment (normal and OA controls). Each bar represents the mean SD. P< 0.05 relative to the respective control.
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Fig. 5B) chondrocytes relative to the respective controls maintained in
RGM, which persisted up to, at least, 72h. Yet, exposure to high
glucose for 24 and 72h signiﬁcantly reduced the inhibitory effect of
TGF on MMP-1 expression, either in normal or OA chondrocytes
(Fig. 5A and B, respectively), which corresponds to higher MMP-1
mRNA levels. At 48h, no signiﬁcant differences were found between
the responses to TGF treatment in the presence or absence of HGM,
either in normal or in OA chondrocytes.
Moreover, treatment of normal (Fig. 5C) and OA (Fig. 5D) human
chondrocytes with TGF in RGM induced a marked and sustained
decrease in MMP-13 expression that was maximal at 72 h
(0.33 0.11 and 0.25 0.09, respectively). Under high glucose
(HGM), however, the inhibitory effect of TGF treatment was
abolished, but the kinetics in normal and OA chondrocytes were not
identical. Indeed, in normal chondrocytes, exposure to high glucose
for 24 h completely reversed the effect of TGF on MMP-13 mRNA
levels, but more prolonged culture periods under high glucose,
namely 48 and 72 h, no longer signiﬁcantly affected the response to
TGF. In OA chondrocytes cultured in HGM for 24 h, the response to
TGF was completely abolished and still signiﬁcant at 48 h. Full
recovery of the ability of TGF to reduce MMP-13 mRNA levels in the
presence of HGM occurred only upon culture for 72 h.
ROLE OF HIGH GLUCOSE IN MODULATING TGF-INDUCED TIMP-1
AND -2 GENE EXPRESSION IN NORMAL AND OA CHONDROCYTES
Figure 6A shows that in normal chondrocytes, TIMP-1 expression was
only slight and transiently increased by treatment with TGF for 48 h in
RGM and was not modiﬁed by exposure to high glucose. In OA
Fig. 4. Role of high glucose in modulating the expression of collagen type I and II genes in normal and OA chondrocytes. Relative collagen type I (A, B) and collagen type II
(C, D) mRNA levels in normal (n¼ 5) and OA (n¼ 5) chondrocytes cultured in medium with an elevated (30mM) glucose concentration (HGM) for 24, 48, and 72 h or
maintained in medium with the regular glucose concentration (RGM) for the entire experiment (normal and OA controls). Each bar represents the mean SD. P< 0.05 and
P< 0.01 relative to the respective control.
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chondrocytes, however, TIMP-1 expression (Fig. 6B) was signiﬁcantly
induced in a time-dependent manner upon TGF treatment, but
independently of the glucose concentration in the culture medium.
In contrast, TGF induced TIMP-2 mRNA expression in normal
chondrocytes (Fig. 6C) relative to the respective control cells. The
observed increase was time-dependent and maximal at 72 h
(2.7 0.26). As shown in Figure 6D, in OA chondrocytes, TGF-
induced TIMP-2 mRNA levels were similar and signiﬁcantly
augmented at the three time points, but the relative increase was
lower than that observed in normal chondrocytes. Induction of TIMP-
2 mRNA levels by TGF was not affected by the glucose concentration
in the culture medium, either in normal or OA chondrocytes.
ROLE OF HIGH GLUCOSE IN MODULATING COLLAGEN I AND II GENE
EXPRESSION INDUCED BY TGF IN NORMAL AND OA
CHONDROCYTES
The results presented in Figure 7A and B show that treatment with
TGF increased collagen I mRNA levels both in normal and OA
chondrocytes and independently of the glucose concentration in the
culture media. Interestingly, the relative increase in collagen I
expression was signiﬁcantly higher in OA than in normal
chondrocytes. Indeed, treatment of this group with TGF for 24
and 48 h increased collagen I mRNA levels to 2.0 0.2 and 2.1 0.5
(Fig. 7A), respectively, whereas in OA chondrocytes the increases
were 3.8 0.8 and 2.5 0.5 (Fig. 7B), respectively, relative to the
corresponding cells maintained in RGM in the absence of TGF
treatment. Additionally, collagen I mRNA levels remained signiﬁ-
cantly elevated in OA chondrocytes treated with TGF for 72 h
(2.7 0.8), while in normal chondrocytes those levels (1.6 0.5)
were not signiﬁcantly different from the respective control group.
Treatment of normal chondrocytes with TGF for 24 and 48 h,
regardless of the presence or absence of high glucose, increased
collagen II mRNA levels, but the differences did not reach statistical
signiﬁcance (Fig. 7C). In contrast, collagen II expression in OA
chondrocytes was signiﬁcantly increased by TGF treatment
(Fig. 7D). The relative increase in collagen II expression was
Fig. 5. Role of high glucose in modulatingMMP-1 and -13 gene expression induced by TGF in normal and OA chondrocytes. Relative mRNA levels of MMP-1 (A, B) andMMP-
13 (C, D) in normal (n¼ 5) and OA (n¼ 6) chondrocytes. Chondrocytes were treated with TGF 10 ng/ml, for 24, 48, and 72 h in medium with a high (30mM, HGM) or regular
(10mM, RGM) glucose concentration or left untreated under RGM (normal and OA controls). P< 0.01 and P< 0.001 relative to the respective control; #P< 0.05,
##P< 0.01 and ###P< 0.001 between TGF in RGM and in HGM for each time point.
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maximal at 24 h (2.2 0.6), slightly decreasing thereafter (1.7 0.3
and 2.1 0.6 at 48 and 72 h, respectively). Culture under high
glucose did not signiﬁcantly alter the response to TGF, except at 72 h
when a small, but statistically signiﬁcant increase was found
(2.5 0.6, P¼ 0.008).
DISCUSSION
The results presented in Figure 1 are in agreement with previous
reports showing that MMP-1 and -13 expression is higher in OA
than in normal chondrocytes [Bau et al., 2002; Kevorkian et al.,
2004]. Moreover, the average ratio of collagen type II expression
over collagen type I (Col II/Col I) was found to be higher in normal
than in OA chondrocytes, likely due to the shift towards increased
collagen I and decreased collagen II expression in OA chondrocytes
(Fig. 1E and F). Nonetheless, this difference did not reach statistical
signiﬁcance, reﬂecting a great variability between individuals in
each group that only much larger cohorts would minimize. The Col
II/Col I ratio has been deﬁned as a chondrocyte differentiation index
and used to characterize normal and OA cartilage and the
differentiation state of monolayer chondrocyte cultures, where
lower ratios correspond to a less differentiated phenotype [Martin
et al., 2001; Marlovits et al., 2004]. Even so, since we could not
obtain age-matched normal and OA cartilage samples and given the
relatively large age range in each group, the possibility that the
differences observed are age-related cannot be excluded.
The major purpose of this study was to determine whether
variations in the extracellular glucose concentration affect
chondrocyte anabolic and catabolic gene expression. The results
obtained show that human chondrocytes respond to the extracellu-
lar glucose concentration which can modulate anabolic and
catabolic responses, both directly and by modifying the response
to anabolic growth factors, namely TGF. In particular, this study
shows that exposure of OA chondrocytes to high glucose (30mM)
increased MMP-1 and -13 mRNA expression and slight and
Fig. 6. Role of high glucose in modulating TIMP-1 and TIMP-2 gene expression induced by TGF in normal and OA chondrocytes. Relative mRNA levels of TIMP-1 (A, B) and
TIMP-2 (C, D) in normal (n¼ 6) and OA (n¼ 6) chondrocytes. Chondrocytes were treated with TGF 10ng/ml for 24, 48, and 72 h in mediumwith a high (30mM, HGM) or regular
(10mM, RGM) glucose concentration or left untreated under RGM (normal and OA controls). P< 0.05, P< 0.01, and P< 0.001 relative to the respective control;
#P< 0.05 and ##P< 0.01 between TGF in RGM and in HGM for each time point.
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transiently augmented collagen II expression, while TIMP-1, TIMP-2
and collagen I were not affected. In contrast, the expression of
MMP-13 and collagen I was not affected by high glucose in
normal chondrocytes, whereas MMP-1 and TIMP-1 expression
were decreased and TIMP-2 and collagen II levels were transitorily
increased. These results indicate that exposure to high glucose
can promote both catabolic and anabolic responses in human
chondrocytes, but OA chondrocytes are more susceptible to
deleterious effects than their normal counterparts. This is in
agreement with our previous study showing that OA chondrocytes
fail to downregulate glucose transport and produce more ROS over
longer periods when exposed to high glucose [Rosa et al., 2009].
On the other hand, most of the effects induced by exposure of
either normal or OA chondrocytes to high glucose were transient.
Two mechanisms may contribute to the reversibility of those effects.
On one hand, glucose concentration in the culture medium decreases
over time due to cell consumption, which may cause the initial effect
to gradually wear out. On the other hand, it is also possible that
the effects at the level of gene expression are transient, while at the
protein level the alterations last longer. Although beyond its scope,
this study paves the way for future research on the role of high
glucose in modulating the protein levels of the genes whose
expression was found to be altered, as well as of other proteins
relevant in chondrocyte biology and arthritis pathology.
Moreover, the observation that in OA chondrocytes high glucose-
induced MMP-1 and -13 mRNA expression was not accompanied by
increased TIMP-1 and -2 expression, suggests that the uncoordi-
nated expression of the MMP/TIMP system can lead to a greater
imbalance in the activity of the former, favoring matrix degradation
and further compromising OA cartilage integrity. Therefore, this
may represent a relevant pathological mechanism by which high
glucose concentrations can contribute to OA pathology. On the other
hand, exposure to a high glucose concentration did not affect TGF-
induced anabolic responses, except for a slight increase in collagen
II mRNA levels (Fig. 7D), but it did reverse TGF-induced anti-
catabolic gene expression. In particular, elevated glucose inhibited
TGF-induced decrease in MMP-13 expression both in normal and
OA chondrocytes, although the effect was more prolonged in OA
Fig. 7. Role of high glucose in modulating Collagens type I and II gene expression induced by TGF in normal and OA chondrocytes. Relative mRNA levels of collagen I (A, B) and
collagen II (C, D) in normal (n¼ 5) and OA (n¼ 5) chondrocytes treated with TGF, 10 ng/ml, for 24, 48, and 72 h in medium with a high (30mM, HGM) or regular (10mM, RGM)
glucose concentration or left untreated under RGM (normal and OA controls). P< 0.05 and P< 0.01 relative to the respective control; #P< 0.01 between TGF in RGM and in
HGM for each time point.
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chondrocytes (Fig. 5C and D). This may constitute another
mechanism by which high glucose concentrations can cause further
damage to chondrocytes and articular cartilage. The oxidative stress
induced by high glucose in OA and also in normal chondrocytes,
although for signiﬁcantly shorter periods in the later [Rosa et al.,
2009], may impair normal TGF signaling and consequent responses.
Indeed, increased ROS production has been shown to induce the
gene expression of various MMPs in chondrocytes from different
species [Lo et al., 1998; Gurjar et al., 2001]. Thus, it is possible that
high glucose-induced ROS, especially in OA chondrocytes,
overcome the inhibitory response induced by TGF, so that MMP-
13 gene expression takes longer to be downregulated by TGF when
the cells are cultured under high glucose.
These ﬁndings are especially important in conditions character-
ized by abnormal glycemic regulation, namely in diabetes mellitus
(DM) patients, where signiﬁcant variations in glycemia and synovial
ﬂuid glucose concentration frequently occur [Brannan and Jerrard,
2006]. In those circumstances, high extracellular glucose concen-
trations may counteract TGF effects and eventually those of other
anabolic growth factors, such as IGF [Kelley et al., 1999], suggesting
that hyperglycemia may be an initiating and/or aggravating factor
linking DM to OA.
Finally and from another point of view, chondrocytes are
frequently exposed in vitro to high glucose concentrations during
production of tissue-engineered cartilage. Indeed, it is current
practice to use culture media with a high glucose content (4.5 g/L,
corresponding to 25mM) for cartilage tissue engineering [Hennig
et al., 2007; Marsano et al., 2007; Das et al., 2008; Appel et al., 2009].
Furthermore, OA cartilage is being increasingly used as a source of
chondroprogenitor cells for cartilage tissue engineering [Agar et al.,
2011]. Therefore, the results presented in this study warrant caution
as to possible deleterious effects of such culture conditions on the
chondrogenic differentiation of those cells and on maintenance of
the chondrocyte phenotype which directly affect the quality and
consequently the in vivo efﬁcacy of the engineered cartilage thus
produced.
In conclusion, our study shows that the extracellular glucose
concentration has an important role in modulating the expression of
genes that are vital for maintenance of the articular cartilage matrix
homeostasis. Exposure to high glucose concentrations favors the
chondrocyte catabolic gene expression program and may, therefore,
promote articular cartilage degradation, facilitating the develop-
ment and/or progression of OA. Moreover, induction of the
chondrocyte catabolic program can also compromise the quality
and consequent in vivo efﬁcacy of tissue engineered cartilage.
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